loadpatents
name:-0.036182880401611
name:-0.025110006332397
name:-0.0012280941009521
Kandimalla; Ekambar R. Patent Filings

Kandimalla; Ekambar R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kandimalla; Ekambar R..The latest application filed is for "immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response".

Company Profile
0.57.61
  • Kandimalla; Ekambar R. - Hopkinton MA
  • Kandimalla; Ekambar R. - Southboro MA
  • Kandimalla; Ekambar R. - Cambridge MA
  • Kandimalla; Ekambar R - Southboro MA US
  • KANDIMALLA; EKAMBAR R. - SOUTHBOROUGH MA
  • Kandimalla; Ekambar R. - US
  • Kandimalla; Ekambar R. - Worcester MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 10,066,230 - Kandimalla , et al. September 4, 2
2018-09-04
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 10,041,076 - Kandimalla , et al. August 7, 2
2018-08-07
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20180023085 - Kandimalla; Ekambar R. ;   et al.
2018-01-25
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20170233741 - Kandimalla; Ekambar R. ;   et al.
2017-08-17
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20170145417 - Kandimalla; Ekambar R. ;   et al.
2017-05-25
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,540,651 - Kandimalla , et al. January 10, 2
2017-01-10
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160312225 - Kandimalla; Ekambar R. ;   et al.
2016-10-27
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,453,228 - Kandimalla , et al. September 27, 2
2016-09-27
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160215287 - Kandimalla; Ekambar R. ;   et al.
2016-07-28
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20160138022 - Kandimalla; Ekambar R. ;   et al.
2016-05-19
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,260,719 - Kandimalla , et al. February 16, 2
2016-02-16
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 9,243,050 - Kandimalla , et al. January 26, 2
2016-01-26
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,206,430 - Kandimalla , et al. December 8, 2
2015-12-08
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 9,096,858 - Kandimalla , et al. August 4, 2
2015-08-04
Stabilized immunomodulatory oligonucleotides
Grant 8,946,175 - Kandimalla , et al. February 3, 2
2015-02-03
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20140308300 - Kandimalla; Ekambar R. ;   et al.
2014-10-16
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20140193396 - Kandimalla; Ekambar R. ;   et al.
2014-07-10
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 8,759,310 - Kandimalla , et al. June 24, 2
2014-06-24
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 8,716,253 - Kandimalla , et al. May 6, 2
2014-05-06
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20140004100 - Kandimalla; Ekambar R. ;   et al.
2014-01-02
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20130267583 - Kandimalla; Ekambar R. ;   et al.
2013-10-10
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20130202584 - Kandimalla; Ekambar R. ;   et al.
2013-08-08
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,486,908 - Kandimalla , et al. July 16, 2
2013-07-16
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 8,476,416 - Kandimalla , et al. July 2, 2
2013-07-02
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,377,898 - Kandimalla , et al. February 19, 2
2013-02-19
Stabilized immune modulatory RNA (SIMRA) compounds
Grant 8,362,233 - Kandimalla , et al. January 29, 2
2013-01-29
Synthetic agonists of TLR9
Grant 8,361,986 - Kandimalla , et al. January 29, 2
2013-01-29
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Grant 8,357,665 - Kandimalla , et al. January 22, 2
2013-01-22
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Utilizing Modified Immunostimulatory Dinucleotides
App 20120201807 - Agrawal; Sudhir ;   et al.
2012-08-09
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 8,202,850 - Agrawal , et al. June 19, 2
2012-06-19
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20120128699 - Kandimalla; Ekambar R. ;   et al.
2012-05-24
Synergistic Treatment Of Cancer Using Immunomers In Conjunction With Chemotherapeutic Agents
App 20120107303 - Kandimalla; Ekambar R. ;   et al.
2012-05-03
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 8,153,608 - Agrawal , et al. April 10, 2
2012-04-10
Novel Agonists Of Toll-like Receptor 3 And Methods Of Their Use
App 20120034248 - KANDIMALLA; EKAMBAR R. ;   et al.
2012-02-09
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
Grant 8,106,173 - Kandimalla , et al. January 31, 2
2012-01-31
Novel Synthetic Agonists Of Tlr9
App 20110311518 - KANDIMALLA; EKAMBAR R. ;   et al.
2011-12-22
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 8,030,462 - Kandimalla , et al. October 4, 2
2011-10-04
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Optimal Presentation Of 5' Ends
App 20110229456 - AGRAWAL; SUDHIR ;   et al.
2011-09-22
Stabilized immunomodulatory oligonucleotides
Grant 8,008,267 - Kandimalla , et al. August 30, 2
2011-08-30
Modulation Of Immunostimulatory Properties Of Oligonucleotide-based Compounds By Utilizing Modified Immunostimulatory Dinucleotides
App 20110150863 - Agrawal; Sudhir ;   et al.
2011-06-23
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 7,932,367 - Kandimalla , et al. April 26, 2
2011-04-26
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
Grant 7,875,594 - Kandimalla , et al. January 25, 2
2011-01-25
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Grant 7,851,453 - Agrawal , et al. December 14, 2
2010-12-14
Short immunomodulatory oligonucleotides
Grant 7,851,454 - Agrawal , et al. December 14, 2
2010-12-14
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 7,833,538 - Kandimalla , et al. November 16, 2
2010-11-16
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 7,824,696 - Kandimalla , et al. November 2, 2
2010-11-02
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,812,000 - Agrawal , et al. October 12, 2
2010-10-12
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
App 20100254974 - Agrawal; Sudhir ;   et al.
2010-10-07
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 7,790,168 - Kandimalla , et al. September 7, 2
2010-09-07
Immunostimulatory activity of immune modulatory oligonucleotides (IMO.TM.) containing different lengths of palindromic segments
Grant 7,786,089 - Kandimalla , et al. August 31, 2
2010-08-31
Immunostimulatory Activity Of Palindromic Immune Modulatory Oligonucleotides (imo) Containing Different Lengths Of Palindromic Segments
App 20100215646 - Kandimalla; Ekambar R. ;   et al.
2010-08-26
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,749,975 - Agrawal , et al. July 6, 2
2010-07-06
Immunostimulatory Properties Of Oligonucleotide-based Compounds Comprising Modified Immunostimulatory Dinucleotides
App 20100143328 - Agrawal; Sudhir ;   et al.
2010-06-10
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
Grant 7,713,535 - Agrawal , et al. May 11, 2
2010-05-11
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
Grant 7,709,617 - Kandimalla , et al. May 4, 2
2010-05-04
Epidermal growth factor receptor antisense oligonucleotides
Grant 7,671,035 - Agrawal , et al. March 2, 2
2010-03-02
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
Grant 7,569,554 - Kandimalla , et al. August 4, 2
2009-08-04
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20090098063 - Kandimalla; Ekambar R. ;   et al.
2009-04-16
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,517,862 - Agrawal , et al. April 14, 2
2009-04-14
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
App 20090060898 - Kandimalla; Ekambar R. ;   et al.
2009-03-05
Novel Synthetic Agonists Of Tlr9
App 20090053206 - Kandimalla; Ekambar R. ;   et al.
2009-02-26
Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
App 20080279785 - Kandimalla; Ekambar R. ;   et al.
2008-11-13
Synergistic Treatment Of Cancer Using Immunomers In Conjunction With Chemotherapeutic Agents
App 20080206265 - Kandimalla; Ekambar R. ;   et al.
2008-08-28
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,407,944 - Agrawal , et al. August 5, 2
2008-08-05
Stabilized Immune Modulatory Rna (simra) Compounds For Tlr7 And Tlr8
App 20080171712 - Kandimalla; Ekambar R. ;   et al.
2008-07-17
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20080152662 - Agrawal; Sudhir ;   et al.
2008-06-26
Immune Regulatory Oligonucleotide (iro) Compounds To Modulate Toll-like Receptor Based Immune Response
App 20080089883 - Kandimalla; Ekambar R. ;   et al.
2008-04-17
Short immunomodulatory oligonucleotides
Grant 7,354,907 - Agrawal , et al. April 8, 2
2008-04-08
Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes
App 20080027214 - Kandimalla; Ekambar R. ;   et al.
2008-01-31
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
Grant 7,276,489 - Agrawal , et al. October 2, 2
2007-10-02
Immunostimulatory activity of immune modulatory oligonucleotides (IMOtm) containing different lengths of palindromic segments
App 20070219153 - Kandimalla; Ekambar R. ;   et al.
2007-09-20
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
Grant 7,262,286 - Kandimalla , et al. August 28, 2
2007-08-28
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20070173469 - Agrawal; Sudhir ;   et al.
2007-07-26
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
App 20070105800 - Agrawal; Sudhir ;   et al.
2007-05-10
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20070072198 - Kandimalla; Ekambar R. ;   et al.
2007-03-29
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
Grant 7,176,296 - Agrawal , et al. February 13, 2
2007-02-13
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20060287262 - Agrawal; Sudhir ;   et al.
2006-12-21
Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
App 20060217328 - Kandimalla; Ekambar R. ;   et al.
2006-09-28
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20060211641 - Agrawal; Sudhir ;   et al.
2006-09-21
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
Grant 7,105,495 - Agrawal , et al. September 12, 2
2006-09-12
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20060142224 - Kandimalla; Ekambar R. ;   et al.
2006-06-29
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20060135454 - Kandimalla; Ekambar R. ;   et al.
2006-06-22
Synergistic inhibition of VEGF and modulation of the immune response
App 20060105979 - Agrawal; Sudhir ;   et al.
2006-05-18
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
App 20060074040 - Kandimalla; Ekambar R. ;   et al.
2006-04-06
Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
App 20060052319 - Agrawal; Sudhir ;   et al.
2006-03-09
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20060019909 - Agrawal; Sudhir ;   et al.
2006-01-26
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20060019918 - Agrawal; Sudhir ;   et al.
2006-01-26
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
App 20050130918 - Agrawal, Sudhir ;   et al.
2005-06-16
Hybridization-based fluorescence assay
App 20050089915 - Kandimalla, Ekambar R. ;   et al.
2005-04-28
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20050026858 - Kandimalla, Ekambar R. ;   et al.
2005-02-03
Stabilized immunomodulatory oligonucleotides
App 20050026861 - Kandimalla, Ekambar R. ;   et al.
2005-02-03
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
App 20050009773 - Kandimalla, Ekambar R. ;   et al.
2005-01-13
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20040266709 - Kandimalla, Ekambar R. ;   et al.
2004-12-30
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20040266710 - Kandimalla, Ekambar R. ;   et al.
2004-12-30
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
App 20040198685 - Agrawal, Sudhir ;   et al.
2004-10-07
Short immunomodulatory oligonucleotides
App 20040156825 - Agrawal, Sudhir ;   et al.
2004-08-12
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
App 20040097719 - Agrawal, Sudhir ;   et al.
2004-05-20
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
App 20030236211 - Agrawal, Sudhir ;   et al.
2003-12-25
Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
App 20030232767 - Agrawal, Sudhir ;   et al.
2003-12-18
Antisense oligonucleotides and methods to induce tumor cell death
App 20030125287 - Kandimalla, Ekambar R. ;   et al.
2003-07-03
Cooperative oligonucleotides
App 20030099959 - Kandimalla, Ekambar R. ;   et al.
2003-05-29
Epidermal growth factor receptor antisense oligonucleotides
App 20030045494 - Agrawal, Sudhir ;   et al.
2003-03-06
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
App 20020137714 - Kandimalla, Ekambar R. ;   et al.
2002-09-26
Pseudo-cyclic oligonucleobases
Grant 6,383,752 - Agrawal , et al. May 7, 2
2002-05-07
Cooperative oligonucleotides
Grant 6,372,427 - Kandimalla , et al. April 16, 2
2002-04-16
Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
Grant 5,912,332 - Agrawal , et al. June 15, 1
1999-06-15
Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
Grant 5,886,165 - Kandimalla , et al. March 23, 1
1999-03-23
Integrated oligonucleotides
Grant 5,739,308 - Kandimalla , et al. April 14, 1
1998-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed